Vizjak Alenka, Ferluga Dusan, Rozic Mojca, Hvala Anastazija, Lindic Jelka, Levart Tanja Kersnik, Jurcić Vesna, Jennette J Charles
Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia.
J Am Soc Nephrol. 2008 Nov;19(11):2237-44. doi: 10.1681/ASN.2007080929. Epub 2008 Jul 23.
C1q nephropathy is an uncommon glomerular disease with characteristic features on immunofluorescence microscopy. In this report, clinicopathologic correlations and outcomes are presented for 72 patients with C1q nephropathy. The study comprised 82 kidney biopsies from 28 children and 54 adults with male preponderance (68%). Immunofluorescence microscopy showed dominant or co-dominant staining for C1q in the mesangium and occasional glomerular capillary walls. Electron-dense deposits were observed in 48 of 53 cases. Light microscopy revealed no lesions (n = 27), focal segmental glomerulosclerosis (FSGS; n = 11), proliferative glomerulonephritis (n = 20), or various other lesions (n = 14). Clinical presentations in the patients who had no lesions histology were normal urine examination (7%), asymptomatic hematuria and/or proteinuria (22%), and nephrotic syndrome (minimal change-like lesion; 63%), which frequently relapsed. All patients with FSGS presented with nephrotic syndrome. Those with proliferative glomerulonephritis usually presented with chronic kidney disease (75%) or asymptomatic urine abnormalities (20%). Of the patients with sufficient follow-up data, complete remission of the nephrotic syndrome occurred in 77% of those with a minimal change-like lesion, progression to end-stage renal disease occurred in 33% of those with FSGS, and renal disease remained stable in 57% of those with proliferative glomerulonephritis. In conclusion, this study identified two predominant clinicopathologic subsets of C1q nephropathy: (1) Podocytopathy with a minimal change-like lesion or FSGS, which typically presents with nephrotic syndrome, and (2) a typical immune complex-mediated glomerular disease that varies from no glomerular lesions to diverse forms of glomerular proliferation, which typically presents as chronic kidney disease. Clinical presentation, histology, outcomes, and presumably pathogenesis of C1q nephropathy are heterogeneous.
C1q肾病是一种罕见的肾小球疾病,在免疫荧光显微镜下具有特征性表现。在本报告中,呈现了72例C1q肾病患者的临床病理相关性及预后情况。该研究包括对28名儿童和54名成年人(男性占优势,68%)的82份肾活检标本。免疫荧光显微镜显示系膜区C1q呈显性或共显性染色,偶尔肾小球毛细血管壁也有染色。53例中有48例观察到电子致密沉积物。光镜检查显示无病变(n = 27)、局灶节段性肾小球硬化(FSGS;n = 11)、增生性肾小球肾炎(n = 20)或其他各种病变(n = 14)。组织学无病变患者的临床表现为尿常规检查正常(7%)、无症状血尿和/或蛋白尿(22%)以及肾病综合征(微小病变样病变;63%),且常复发。所有FSGS患者均表现为肾病综合征。增生性肾小球肾炎患者通常表现为慢性肾脏病(75%)或无症状尿液异常(20%)。在有足够随访数据的患者中,微小病变样病变患者77%肾病综合征完全缓解,FSGS患者33%进展至终末期肾病,增生性肾小球肾炎患者57%肾病稳定。总之,本研究确定了C1q肾病的两个主要临床病理亚组:(1)具有微小病变样病变或FSGS的足细胞病,通常表现为肾病综合征;(2)典型的免疫复合物介导的肾小球疾病,从无肾小球病变到各种形式的肾小球增生不等,通常表现为慢性肾脏病。C1q肾病的临床表现、组织学、预后以及推测的发病机制具有异质性。